SCHEMBL7107467

SCHEMBL7107467

CNC(=S)NS(=O)(=O)c1cc(CCNC(=O)/C=C/c2ccc(OC)cc2OC)ccc1Oc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LY96 Q9Y6Y9 1/20 0.52
ABCC9 O60706 1/20 0.51
ABCC8 Q09428 1/20 0.51
KCNJ11 Q14654 1/20 0.51
LMNA P02545 2/20 0.49
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
MAPT P10636 5/20 0.47
ACHE P22303 3/20 0.46
BCHE P06276 1/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
OPRM1 P35372 1/20 0.46
OPRD1 P41143 1/20 0.46
KDM4E B2RXH2 2/20 0.44
MAPK1 P28482 1/20 0.44
ALOX5 P09917 1/20 0.43
ALDH1A1 P00352 2/20 0.43
PKM P14618 1/20 0.43
MAOA P21397 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7107471 1.00 LY96 (0.52) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL4256436 0.93 ABCC9 (0.59) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL7113055 0.93 ABCC9 (0.59) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL7112814 0.91 PTGER4 (0.51) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL7112818 0.91 PTGER4 (0.51) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL7114286 0.89 LY96 (0.52) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL7114281 0.89 LY96 (0.52) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL7108288 0.88 LY96 (0.52) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL5578528 0.88 ABCC9 (0.53) LY96ABCC9ABCC8KCNJ11LMNA
SCHEMBL7108290 0.88 LY96 (0.52) LY96ABCC9ABCC8KCNJ11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183236-B1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AVENTIS PHARMA GMBH (DE) 2003-10-22 EP disclosed
EP-1183236-A1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES Aventis Pharma Deutschland GmbH (DE) 2002-03-06 EP disclosed
US-6350778-B1 CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-02-26 US disclosed
WO-2000071513-A1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-30 WO disclosed